Author
Listed:
- Fei Tian
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Shaohua Zhang
(Chinese PLA General Hospital)
- Chao Liu
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Ziwei Han
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Yuan Liu
(National Center for Nanoscience and Technology)
- Jinqi Deng
(National Center for Nanoscience and Technology)
- Yike Li
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Xia Wu
(Chinese PLA General Hospital)
- Lili Cai
(Chinese PLA General Hospital)
- Lili Qin
(Chinese PLA General Hospital)
- Qinghua Chen
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Yang Yuan
(Chinese PLA General Hospital)
- Yi Liu
(Chinese PLA General Hospital)
- Yulong Cong
(Chinese PLA General Hospital)
- Baoquan Ding
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Zefei Jiang
(Chinese PLA General Hospital)
- Jiashu Sun
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
Abstract
Molecular profiling of circulating extracellular vesicles (EVs) provides a promising noninvasive means to diagnose, monitor, and predict the course of metastatic breast cancer (MBC). However, the analysis of EV protein markers has been confounded by the presence of soluble protein counterparts in peripheral blood. Here we use a rapid, sensitive, and low-cost thermophoretic aptasensor (TAS) to profile cancer-associated protein profiles of plasma EVs without the interference of soluble proteins. We show that the EV signature (a weighted sum of eight EV protein markers) has a high accuracy (91.1 %) for discrimination of MBC, non-metastatic breast cancer (NMBC), and healthy donors (HD). For MBC patients undergoing therapies, the EV signature can accurately monitor the treatment response across the training, validation, and prospective cohorts, and serve as an independent prognostic factor for progression free survival in MBC patients. Together, this work highlights the potential clinical utility of EVs in management of MBC.
Suggested Citation
Fei Tian & Shaohua Zhang & Chao Liu & Ziwei Han & Yuan Liu & Jinqi Deng & Yike Li & Xia Wu & Lili Cai & Lili Qin & Qinghua Chen & Yang Yuan & Yi Liu & Yulong Cong & Baoquan Ding & Zefei Jiang & Jiashu, 2021.
"Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer,"
Nature Communications, Nature, vol. 12(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22913-7
DOI: 10.1038/s41467-021-22913-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22913-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.